Exchange: NASDAQ Capital Market Sector: Financial Services Industry: Shell Companies
0.00% $10.04
/ 28 okt 2022 @ 15:59
RATING 2022-11-14 |
---|
A- |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Neutral | |
Return On Asset: | Neutral | |
DE: | Neutral | |
P/E: | Buy | |
Price To Book: | Neutral |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
1/21 | 2/21 | 3/21 | 4/21 | 1/22 | 2/22 | |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gr.Profit | n/a | n/a | n/a | |||
Ebit | ||||||
Asset | ||||||
Debt | n/a | n/a | n/a | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 22.07 | sector: PE 0 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE 22.07 | industry: PE 0 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 10.00 - 10.08 ( +/- 0.44%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2020-10-30 | Sarissa Capital Acquisition Sponsor Llc | Sell | 31 250 | Class B ordinary shares |
2020-10-23 | Paglia Louis J | Buy | 6 000 | Units |
2020-10-23 | Sarissa Capital Acquisition Sponsor Llc | Buy | 3 333 333 | Warrants to purchase Class A ordinary shares |
2020-10-20 | Sarissa Capital Acquisition Sponsor Llc | Sell | 5 031 250 | Class B ordinary shares |
2020-10-20 | Bonfiglio Patrice Eadon | Buy | 0 |
INSIDER POWER |
---|
0.00 |
Last 4 transactions |
Buy: 3 339 333 | Sell: 5 062 500 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $10.04 (0.00% ) |
Volume | 0.0003 mill |
Avg. Vol. | 0.0007 mill |
% of Avg. Vol | 38.97 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Sarissa Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify and acquire a business, which focuses on the healthcare and biopharmaceutical industry. Sarissa Capital Acquisition Corp. was incorporated in 2020 and is based in Greenwich, Connecticut.